Result of AGM - Replacement
MedPal AI plc announced that all resolutions were passed at its annual general meeting, with strong support for director reappointments and auditor reappointment, although the auditors were corrected to RPGC Crouch Chapman LLP. The company reported that 224,958,485 votes were cast in favour of receiving the annual report and accounts, representing 45.68% of the issued share capital. Similarly, resolutions to reappoint directors Jason Drummond, Kevin O'Neill, Justin Drummond, and Adam Monaco, and to reappoint RPGC Crouch Chapman LLP as auditors, all received over 99.95% of votes in favour. Authorisation for directors to allot shares and disapply pre-emption rights also passed with high percentages.
Select text to share a quote on X · sign in to keep highlights & notes in your MPAL notes
This announcement replaces the announcement of 30 March 2026. The Company's auditors being reappointed per resolution 6 are RPGC Crouch Chapman LLP, not Grant Thornton Limited as previously stated. All other details remain the same.
MedPal AI plc (AIM:MPAL, FRA Z1N), the digital health and AI company, announces that, at the annual general meeting of the Company held today, all of the resolutions were passed. The results of the poll vote are set out below.
| Summary of Resolutions | For | Percentage of votes in Favour | Against | Percentage of votes Against | Withheld | Total of issued share capital voted | Percentage of issued share capital voted |
|---|---|---|---|---|---|---|---|
| 1 R eceive the consolidated annual report and accounts for the year ended 31 August 2025 | 224,919,529 | 99.98% | 38,956 | 0.02% | 116,470 | 224,958,485 | 45.68% |
| 2 Reappoint Jason Drummond as a director of the Company | 224,809,794 | 99.95% | 122,314 | 0.05% | 142,847 | 224,932,108 | 45.68% |
| 3 Reappoint Kevin O'Neill as a director of the Company | 224,811,214 | 99.95% | 120,894 | 0.05% | 142,847 | 224,932,108 | 45.68% |
| 4 Reappoint Justin Drummond as a director of the Company | 224,869,171 | 99.97% | 65,279 | 0.03% | 140,505 | 224,934,450 | 45.68% |
| 5 Reappoint Adam Monaco as a director of the Company | 224,810,542 | 99.95% | 121,391 | 0.05% | 143,022 | 224,931,933 | 45.68% |
| 6 R eappoint RPGC Crouch Chapman LLP as auditors | 224,805,257 | 99.96% | 100,743 | 0.04% | 168,955 | 224,906,000 | 45.67% |
| 7 To authorise the Directors to determine the fees payable to the auditors | 224,632,019 | 99.92% | 190,457 | 0.08% | 252,479 | 224,822,476 | 45.65% |
| 8 To authorise the Directors to allot ordinary shares and relevant securities pursuant to Section 551 of the Companies Act 2006. | 224,514,082 | 99.80% | 445,098 | 0.20% | 115,775 | 224,959,180 | 45.68% |
| 9 To disapply pre-emption rights in certain circumstances (general authority). | 224,643,956 | 99.88% | 271,975 | 0.12% | 159,024 | 224,915,931 | 45.67% |
Notes:
Resolutions 1 to 8 were passed as Ordinary Resolutions. Resolution 9 was passed as a Special Resolution
The number of ordinary shares in issue at the date of this announcement is 492,441,036, of which no ordinary shares are held in treasury.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.